BIOLIFE SOLUTIONS INC
BLFSNASDAQTrading Snapshot
- Day Range
- $38.73 β $39.93
- 52-Week Range
- $17.86 β $39.76
- Volume
- $2.53B
- Avg Volume
- $2.03B
- Shares Outstanding
- 48.9M
- Next Earnings
- Nov 9, 2026
Fundamentals Snapshot
- Annual Revenue
- $96M
- Last Q Revenue
- $28M
- P/E Ratio
- 37.9
- P/S Ratio
- 18.6x
- EPS (TTM)
- $1.03
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +1.3%
Why Investors Own BLFS
- βHigh-growth profile β revenue up +32.9% YoY with expanding US Equity exposure.
- βHealthy economics β 44% gross margin and 20% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
BIOLIFE SOLUTIONS INC
BLFSAbout BIOLIFE SOLUTIONS INC
BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing. Key products include proprietary biopreservation media, such as HypoThermosol FRS and CryoStor, which are engineered to minimize delayed cell damage and death typically associated with preservation. Complementing these are the ThawSTAR products, an automated line of devices for thawing vials and cryobags, designed to precisely manage the heat and timing for optimal biologic material thawing. BLFS also provides innovative cloud-connected evo shipping containers for the passive storage and secure transport of temperature-sensitive biologics and pharmaceuticals. Additionally, its comprehensive range encompasses liquid nitrogen laboratory freezers, various cryogenic equipment and accessories, and specialized storage services for biological and pharmaceutical products. Products are distributed both directly to customers and through a network of third-party distributors. Established in 1987, BioLife Solutions, Inc. maintains its headquarters in Bothell, Washington.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates

Are BLFS, FTHM, AUUD, VRME Obtaining Fair Deals for their Shareholders?
Are BLFS, FTHM, AUUD, VRME Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Sept. 11, 2026Insiders may stand to receive substantial financial be

BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (βKSFβ) are investigating the proposed sale of BioLife Solutions, Inc. (

Bank of New York Mellon Corp Purchases New Shares in BioLife Solutions, Inc. $BLFS
Bank of New York Mellon Corp bought a new position in shares of BioLife Solutions, Inc. (NASDAQ: BLFS) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange C

Qiagen (NYSE:QGEN) & BioLife Solutions (NASDAQ:BLFS) Critical Contrast
BioLife Solutions (NASDAQ: BLFS - Get Free Report) and Qiagen (NYSE: QGEN - Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of

BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of BioLife Solutions, Inc. (NASDAQ: BLFS) to Repligen Corporation for $11.25 per share

IQVIA (NYSE:IQV) versus BioLife Solutions (NASDAQ:BLFS) Head to Head Review
BioLife Solutions (NASDAQ: BLFS - Get Free Report) and IQVIA (NYSE: IQV - Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of th